• Gujarat
More

    Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection

    Must Read

    OSD interacted with relatives of patients and doctors at SSG Vadodara

    Said continuously tries to address the issues between them Officer on Special...

    Covid 19 cases reached 53400 in Vadodara after 954 new cases on Monday

    Total 759 discharged from hospital taking the total to 42769 Witnessing a slight decline...

    Indian Naval ship Trikand arrives at Mumbai as part of operation Samudra Setu 2

    As part of Operation Samudra Setu II, Indian Naval Ship Trikand was deployed to augment shipment of Liquid...

    Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020

    Rhizen Pharmaceuticals S.A., an associate company of Alembic Pharmaceuticals Ltd., which is a clinical-stage oncology-focussed biopharmaceutical company, announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to study its oral DHODH inhibitor for SARS-CoV-2 infection.

    The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020. The company also announces positive feedback from the FDA during its pre-IND discussion on its plans to follow-up this study with a multiple-ascending dose study in Covid-19 patients.

    Dihydroorotate dehydrogenase (DHOHD) is a key enzyme involved in pyrimidine biosynthesis in the cell. RP7214 is potentially a best-in-class selective DHODH inhibitor that has shown potent inhibition of Covid-19 viral replication. RP7214 has also been studied extensively across multiple inflammation models where it has demonstrated excellent anti-inflammatory activity.

    Further, the IND-enabling preclinical studies have shown RP7214 to be orally available, safe and tolerable with predictable dose-linear pharmacokinetics. The host-based mechanism of RP7214 could allow complementary combinations with direct acting anti-viral drugs, while the broad anti-inflammatory action could potentially mitigate the cytokine mediated inflammatory symptoms typically seen in SARS-CoV-2 & other viral infections.

    Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said “There is an exceptional need for oral antiviral drugs that are suitable for Covid-19 treatment across all hospital and out-patient settings. We are pleased to advance RP7214 into a Phase 1 clinical trial for the treatment of Covid-19 under a US FDA IND. RP7214 has a unique preclinical profile, high oral bioavailability, robust anti-viral potency and broad anti-inflammatory role, that we expect will translate in the clinic and support its eventual development as a potential treatment for Covid-19.”

    Talking on this development, Pranav Amin- the Managing Director of Alembic Pharmaceuticals Ltd. said, “Its exciting development that our team Rhizen is working on and we are hoping on, an oral retroviral, which will add a new dimension to treatment of Covid 19”.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Amitabh Bachchan donates Rs 2 crore to COVID-19 care facility in Delhi

    Amitabh Bachchan has donated Rs 2 crore to Sri Guru Tegh Bahadur COVID Care Centre at the...

    Covid 19 cases reached 53400 in Vadodara after 954 new cases on Monday

    Total 759 discharged from hospital taking the total to 42769 Witnessing a slight decline the number of positive cases...

    Indian Naval ship Trikand arrives at Mumbai as part of operation Samudra Setu 2

    As part of Operation Samudra Setu II, Indian Naval Ship Trikand was deployed to augment shipment of Liquid Medical Oxygen (LMO) cryogenic containers...

    Two Indian Air Force IL-76s airlifted 4 Cryogenic Oxygen Containers from Jakarta, Indonesia and landed at Vizag

    An IAF C17 airlifted Zeolite (Respiratory Oxygen raw material) from Frankfurt to Mumbai.  Two other C17s are bringing 02 Oxygen Generators from...

    Huge fire broke out in ST bus carrying passengers from Vadodara to Ahmedabad

    Fortunately 29 passengers including the driver ran to safety in time A huge fire broke out in an ST...

    More Articles Like This

    - Advertisement -